Atlas ArteriaASX:ALX 75 ROE % is 8.08% as of Dec. 2025, which is 36% above its 10-year median of 5.96. GuruFocus rates ASX:ALX with a GF Score™ of 75/100 and a GF Value™ of A$5.86 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,743 Construction companies, Atlas Arteria ranks worse than 52.44% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Atlas Arteria's annualized net income for the quarter that ended in Dec. 2025 was A$372.4 Mil. Atlas Arteria's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was A$4,610.9 Mil. Therefore, Atlas Arteria's annualized ROE % for the quarter that ended in Dec. 2025 was 8.08%.
The historical rank and industry rank for Atlas Arteria's ROE % or its related term are showing as below:
ASX:ALX'
s ROE % Range Over the Past 10 Years
Min: -1.6 Med: 5.96 Max: 32.12
Current: 6.2
During the past 13 years, Atlas Arteria's highest ROE % was 32.12%. The lowest was -1.60%. And the median was 5.96%.
ASX:ALX's ROE % is ranked worse than 52.44% of 1743
companies
in the Construction industry
Industry Median: 6.71
vs ASX:ALX: 6.20
Atlas Arteria (ASX:ALX) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Atlas Arteria ROE % Related Terms
Atlas Arteria ROE % Historical Data
* Premium members only.
The historical data trend for Atlas Arteria's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Infrastructure Operations subindustry, Atlas Arteria's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Atlas Arteria ROE % vs Construction Industry
For the Construction industry and Industrials sector, Atlas Arteria's ROE % distribution charts can be found below:
* The bar in red indicates where Atlas Arteria's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Atlas Arteria (ASX:ALX) has a ROE % of 8.08% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Atlas Arteria and its competitors. This is 36% above median its historical median of 5.96. According to the industry distribution chart, Atlas Arteria ranks #914 out of 1743 companies in the Construction industry, placing it in the top 52.4%.
Is Atlas Arteria's ROE % too high?
Atlas Arteria's current ROE % of 8.08% is 36% above median its 10-year median of 5.96. The Construction industry median ROE % is 6.71. Atlas Arteria's value of 8.08% is 20.4% above this industry median. Based on the distribution chart, Atlas Arteria ranks #914 out of 1743 companies in the Construction industry, which is below the industry midpoint. Overall, Atlas Arteria has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's ROE % compare to competitors?
According to the Construction industry distribution chart, Atlas Arteria ranks #914 out of 1743 companies for ROE %. This places Atlas Arteria in the lower half of its industry. The industry median ROE % is 6.71. Atlas Arteria's value of 8.08% is 20.4% above this benchmark. While the company's 10-year median is 5.96 vs. the industry median of 6.71, Atlas Arteria has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Construction company?
The median ROE % among Construction companies is 6.71, based on 1,743 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Atlas Arteria's current ROE % of 8.08% is 20.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Atlas Arteria and its competitors. For the Construction industry, the median ROE % is 6.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atlas Arteria's current ROE % is 8.08%, which is 36% above median its own 10-year median of 5.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (ASX:ALX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$5.86, compared to a current price of A$5.10 — trading 13% below its estimated fair value. The current ROE % is 8.08%, which is 36% above median its 10-year median of 5.96 and 20.4% above the Construction industry median of 6.71. Atlas Arteria's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Atlas Arteria (ASX:ALX), the current ROE % is 8.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Atlas Arteria (ASX:ALX) Overvalued in 2026?
Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued.
The current stock price of A$5.10 is trading 13% below its estimated GF Value™ of A$5.86.
GuruFocus considers Atlas Arteria to be Modestly Undervalued.
Key valuation signals for ASX:ALX:
ROE %: 8.08% (36% above median its 10-year median of 5.96)
GF Value™: A$5.86 vs. price of A$5.10 (13% below fair value)
Industry Position: 20.4% above the Construction median (#914 of 1743)
No single metric tells the full story. See the ASX:ALX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
75GF Score
Get the complete analysis for ASX:ALX
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALX has been successfully added to your 
